Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

290 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A contribution of mouse dendritic cell-derived IL-2 for NK cell activation.
Granucci F, Zanoni I, Pavelka N, Van Dommelen SL, Andoniou CE, Belardelli F, Degli Esposti MA, Ricciardi-Castagnoli P. Granucci F, et al. Among authors: belardelli f. J Exp Med. 2004 Aug 2;200(3):287-95. doi: 10.1084/jem.20040370. J Exp Med. 2004. PMID: 15289500 Free PMC article.
IFN-alpha in the generation of dendritic cells for cancer immunotherapy.
Santini SM, Lapenta C, Santodonato L, D'Agostino G, Belardelli F, Ferrantini M. Santini SM, et al. Among authors: belardelli f. Handb Exp Pharmacol. 2009;(188):295-317. doi: 10.1007/978-3-540-71029-5_14. Handb Exp Pharmacol. 2009. PMID: 19031032 Review.
Dendritic cells and cytokines in immune rejection of cancer.
Ferrantini M, Capone I, Belardelli F. Ferrantini M, et al. Among authors: belardelli f. Cytokine Growth Factor Rev. 2008 Feb;19(1):93-107. doi: 10.1016/j.cytogfr.2007.10.003. Epub 2007 Dec 3. Cytokine Growth Factor Rev. 2008. PMID: 18054517 Review.
Cyclophosphamide synergizes with type I interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosis.
Schiavoni G, Sistigu A, Valentini M, Mattei F, Sestili P, Spadaro F, Sanchez M, Lorenzi S, D'Urso MT, Belardelli F, Gabriele L, Proietti E, Bracci L. Schiavoni G, et al. Among authors: belardelli f. Cancer Res. 2011 Feb 1;71(3):768-78. doi: 10.1158/0008-5472.CAN-10-2788. Epub 2010 Dec 13. Cancer Res. 2011. PMID: 21156650
290 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page